These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8179303)

  • 21. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
    Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
    Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel ganglioside, 9-O-acetyl GD1b, is recognized by serum antibodies in Guillain-Barré syndrome.
    Hitoshi S; Kusunoki S; Kon K; Chiba A; Waki H; Ando S; Kanazawa I
    J Neuroimmunol; 1996 May; 66(1-2):95-101. PubMed ID: 8964919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ilyas AA; Mithen FA; Dalakas MC; Chen ZW; Cook SD
    J Neurol Sci; 1992 Jan; 107(1):111-21. PubMed ID: 1578228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
    Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome.
    Kusunoki S; Iwamori M; Chiba A; Hitoshi S; Arita M; Kanazawa I
    Neurology; 1996 Jul; 47(1):237-42. PubMed ID: 8710085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
    Ihara Y; Saito K; Yoshimoto S; Hayabara T; Yuki N
    Rinsho Shinkeigaku; 1995 Aug; 35(8):901-3. PubMed ID: 8665735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
    Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
    J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia.
    Kamakura K; Kaida K; Kusunoki S; Miyamoto N; Masaki T; Nakamura R; Motoyoshi K; Fukuda J
    J Peripher Nerv Syst; 2005 Jun; 10(2):190-201. PubMed ID: 15958130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiglycolipid antibody in inflammatory neuropathy].
    Kusunoki S
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1370-2. PubMed ID: 8752399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An acute axonal form of Guillain-Barré syndrome with autoantibody against ganglioside GD1b--a case report].
    Fujii H; Kondo T; Yasuda K; Hiraizumi Y; Yamazaki M; Yuki N
    No To Hattatsu; 1993 Jul; 25(4):379-84. PubMed ID: 8338702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
    Ilyas AA; Mithen FA; Chen ZW; Cook SD
    J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.